Found: 17
Select item for more details and to access through your institution.
Fulditoxin, representing a new class of dimeric snake toxins, defines novel pharmacology at nicotinic ACh receptors.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Molecular dynamics simulations of dihydro-β-erythroidine bound to the human α4β2 nicotinic acetylcholine receptor.
- Published in:
- 2019
- By:
- Publication type:
- journal article
α-Conotoxins active at α3-containing nicotinic acetylcholine receptors and their molecular determinants for selective inhibition.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Structure-Activity Studies of Cysteine-Rich α-Conotoxins that Inhibit High-Voltage-Activated Calcium Channels via GABA<sub>B</sub> Receptor Activation Reveal a Minimal Functional Motif.
- Published in:
- Angewandte Chemie, 2016, v. 128, n. 15, p. 4770, doi. 10.1002/ange.201600297
- By:
- Publication type:
- Article
Structure-Activity Studies of Cysteine-Rich α-Conotoxins that Inhibit High-Voltage-Activated Calcium Channels via GABA<sub>B</sub> Receptor Activation Reveal a Minimal Functional Motif.
- Published in:
- Angewandte Chemie International Edition, 2016, v. 55, n. 15, p. 4692, doi. 10.1002/anie.201600297
- By:
- Publication type:
- Article
Drysdalin, an antagonist of nicotinic acetylcholine receptors highlights the importance of functional rather than structural conservation of amino acid residues.
- Published in:
- FASEB Bioadvances, 2019, v. 1, n. 2, p. 115, doi. 10.1096/fba.1027
- By:
- Publication type:
- Article
MOLECULAR RECOGNITION OF THE DISORDERED DIHYDROPYRIDINE RECEPTOR II–III LOOP BY A CONSERVED SPRY DOMAIN OF THE TYPE 1 RYANODINE RECEPTOR.
- Published in:
- 2009
- By:
- Publication type:
- Other
α‐Conotoxin Bt1.8 from Conus betulinus selectively inhibits α6/α3β2β3 and α3β2 nicotinic acetylcholine receptor subtypes.
- Published in:
- Journal of Neurochemistry, 2021, v. 159, n. 1, p. 90, doi. 10.1111/jnc.15434
- By:
- Publication type:
- Article
Rational Design of Potent α-Conotoxin PeIA Analogues with Non-Natural Amino Acids for the Inhibition of Human α9α10 Nicotinic Acetylcholine Receptors.
- Published in:
- Marine Drugs, 2024, v. 22, n. 3, p. 110, doi. 10.3390/md22030110
- By:
- Publication type:
- Article
Characterisation of Elevenin-Vc1 from the Venom of Conus victoriae : A Structural Analogue of α-Conotoxins.
- Published in:
- Marine Drugs, 2023, v. 21, n. 2, p. 81, doi. 10.3390/md21020081
- By:
- Publication type:
- Article
Unusual Tetrahydropyridoindole-Containing Tetrapeptides with Human Nicotinic Acetylcholine Receptors Targeting Activity Discovered from Antarctica-Derived Psychrophilic Pseudogymnoascus sp. HDN17-933.
- Published in:
- Marine Drugs, 2022, v. 20, n. 10, p. 593, doi. 10.3390/md20100593
- By:
- Publication type:
- Article
Single-Disulfide Conopeptide Czon1107, an Allosteric Antagonist of the Human α3β4 Nicotinic Acetylcholine Receptor.
- Published in:
- Marine Drugs, 2022, v. 20, n. 8, p. 497, doi. 10.3390/md20080497
- By:
- Publication type:
- Article
Identification of a Novel O-Conotoxin Reveals an Unusual and Potent Inhibitor of the Human α9α10 Nicotinic Acetylcholine Receptor.
- Published in:
- Marine Drugs, 2017, v. 15, n. 6, p. 170, doi. 10.3390/md15060170
- By:
- Publication type:
- Article
A Novel Lid-Covering Peptide Inhibitor of Nicotinic Acetylcholine Receptors Derived from αD-Conotoxin GeXXA.
- Published in:
- Marine Drugs, 2017, v. 15, n. 6, p. 164, doi. 10.3390/md15060164
- By:
- Publication type:
- Article
Functional variants in HCN4 and CACNA1H may contribute to genetic generalized epilepsy.
- Published in:
- Epilepsia Open, 2017, v. 2, n. 3, p. 334, doi. 10.1002/epi4.12068
- By:
- Publication type:
- Article
Assembly, trafficking and function of α1β2γ2 GABA<sub>A</sub> receptors are regulated by N-terminal regions, in a subunit-specific manner.
- Published in:
- Journal of Neurochemistry, 2015, v. 134, n. 5, p. 819, doi. 10.1111/jnc.13175
- By:
- Publication type:
- Article
Gabapentin Modulates HCN4 Channel Voltage-Dependence.
- Published in:
- Frontiers in Pharmacology, 2017, p. 1, doi. 10.3389/fphar.2017.00554
- By:
- Publication type:
- Article